Experience with Czechoslovak subunit anti-influenza vaccine
Závadová, H.; Vonka, V.; Stárek, M.; Domorázková, E.; Bruj, J.; Skocil, V.
Casopis Lekaru Ceskych 114(47): 1462-1466
1975
ISSN/ISBN: 0008-7335 PMID: 1203931 Document Number: 92477
Document emailed within 1 workday
Related Documents
Hahn, H.L.; Mössner, J. 1980: Influenza vaccination of risk patients with trivalent split virus vaccine and subunit vaccine Münchener Medizinische Wochenschrift 122(42): 1477-1480Fine, M. 2004: The Rhode Island influenza vaccine experience 1995-2003: influenza vaccine price, reimbursement, availability, and Rhode Island's influenza vaccination rate Medicine and Health Rhode Island 87(3): 79-80
Phillips, C.F.; Phillips, C.A.; Hodgkin, W.E.; Forsyth, B.R.; Rubin, B.A.; Geraghty, M.E. 1973: Killed subunit influenza vaccine in children Pediatrics 52(3): 416-419
Berezin, V.E.; Zaĭdes, V.M.; Isaeva, E.S.; Zhdanov, V.M. 1985: Immunogenicity of a subunit influenza vaccine in experiments on animals Voprosy Virusologii 30(2): 166-174
Feery, B.J.; Evered, M.G.; Morrison, E.I. 1976: Antibody responses to influenza virus subunit vaccine in the aged Medical Journal of Australia 1(15): 540; 542
El'shina, G.A.; Gorbunov, M.A.; Shervarli, V.I.; Lonskaia, N.I.; Pavlova, L.I.; Khaitov, R.M.; Nekrasov, A.V.; Ivanova, A.S.; Matrosovich, M.N.; Puchkova, N.G.; Belashev, V.P.; Malinovskiĭ, A.A. 1998: Evaluation of the effectiveness of influenza trivalent polymer subunit vaccine "Grippol" Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 3: 40-43
Alvarez-Alva, R. 1971: Epidemiologic study on the 1969-1970 influenza outbreak and the antigenic capacity of anti-influenza vaccine. I. Methodology of the epidemiological studies Gaceta Medica de Mexico 101(1): 21-26
2000: Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000-01 influenza season. Advisory Committee on Immunization Practices Mmwr. Morbidity and Mortality Weekly Report 49(27): 619-622
Masurel, N. 1979: Immunization of elderly subjects with subunit and total virus vaccine containing H1N1 influenza virus Nederlands Tijdschrift Voor Geneeskunde 123(6): 196-199
Bernadou, J.M.; Fréour, P. 1970: What can we expect from anti-influenza vaccine? Bordeaux Medical 3(10): 2331
Murphey-Corb, M.; Martin, L.N.; Davison-Fairburn, B.; Montelaro, R.C.; Miller, M.; West, M.; Ohkawa, S.; Baskin, G.B.; Zhang, J.Y.; Putney, S. 1990: A formalin inactivated whole SIV vaccine and a glycoprotein-enriched subunit vaccine confers protection against experimental challenge with pathogenic live SIV in rhesus monkeys Developments in Biological Standardization 72: 273-285
Fedson, D.S.; Fulk, R.V.; Huber, M.A.; Reisberg, M.A.; Kasel, J.A. 1971: Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine Journal of Immunology 107(3): 730-737
Zlydnikov, D.M. 1981: Experience with clinical trials of the new anti-influenza drug rimantadine Vrachebnoe Delo 4: 15-18
Kagami, S.; Urushihara, M.; Kondo, S.; Hayashi, T.; Yamano, H.; Löster, K.; Vossmeyer, Dörte.; Reutter, W.; Kuroda, Y. 2002: Effects of anti-alpha1 integrin subunit antibody on anti-Thy-1 glomerulonephritis Laboratory Investigation; A Journal of Technical Methods and Pathology 82(9): 1219-1227
Nekliudova, L.I.; Fedorova, I.B.; Orlova, N.G. 1974: Correlation of antineuraminidase antibodies and antihemagglutinins in influenza and following administration of live influenza vaccine Voprosy Virusologii 2: 173-176
1995: CDC releases update on influenza activity and on composition of 1995-96 influenza vaccine American Family Physician 52(1): 298-299
Hannoun, C. 1973: A new step in influenza vaccination. I. Prospective vaccine against influenza La Nouvelle Presse Medicale 2(18): 1199-1202
Nakada, S. 1987: New technology of vaccine production--international prospect of the development--subunit vaccine obtained by genetic engineering. b. Genetic engineering method using animal cells Nihon Rinsho. Japanese Journal of Clinical Medicine 45(10): 2326-2332
Guo, W.; Xu, J.; Wu, J.; Zhao, S.; He, H.; Shi, W.; Yu, D.; Li, J.; Gao, H.; Chen, J. 2014: Safety and immunogenicity of seasonal inactivated influenza vaccine (split virion) and cross-reactive antibody responses to the H7N9 avian influenza virus Zhonghua Liu Xing Bing Xue Za Zhi 35(8): 949-952
LaForce, F.M. 2011: Technology transfer to developing country vaccine manufacturers to improve global influenza vaccine production: a success story and a window into the future Vaccine 29(Suppl 1): A1